Product Images Lamotrigine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Lamotrigine NDC 65862-362 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Lamotrigine Tablets (Chewable, Dispersible) - lamotrigine fig1

Lamotrigine Tablets (Chewable, Dispersible) - lamotrigine fig1

The text describes a figure labeled as "Figure 1" showing the Kaplan-Meier estimation of cumulative proportion of patients with mood episode in Trial 1. The figure includes two lines labeled as "Placebo" and "LAMOTRIGINE" and a horizontal axis labeled as "Weeks". The graph shows the probability of having a mood episode over time, with percentages increasing until around week 8-10 and then remaining steady.*

Figure 1: Kaplan-Meier Estimation of Cumulative Proportion of Patients with Mood Episode (Trial 1) - lamotrigine fig2

Figure 1: Kaplan-Meier Estimation of Cumulative Proportion of Patients with Mood Episode (Trial 1) - lamotrigine fig2

The text is a figure caption showing the Kaplan-Meier Estimation of Cumulative Proportion of Patients with a Mood Episode in Trial 2. The figure compares the placebo group to the group taking LAMOTRIGINE. Not available to provide a further description as the image is necessary to understand this data.*

Figure 2: Kaplan-Meier Estimation of Cumulative Proportion of Patients with Mood Episode (Trial 2) - lamotrigine fig3

Figure 2: Kaplan-Meier Estimation of Cumulative Proportion of Patients with Mood Episode (Trial 2) - lamotrigine fig3

Lamotrigine Tablets for Oral Suspension are available in two strengths, 5mg and 25mg. The 5mg tablets are white to off-white and are marked with a "D" on one side. The 25mg tablets are also white to off-white with "D99" on one side and "98" on the other side. They have a plain surface on their another side.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 5 mg (100 Tablets Bottle) - lamotrigine fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 5 mg (100 Tablets Bottle) - lamotrigine fig4

This is a description for Lamotrigine Tablets for Oral Suspension, USP. it is an Rx only medication that is distributed by Aurobindo Pharma USA, Inc. The usual dosage information can be found in the prescribing information. The tablets can be swallowed whole, chewed, or dispersed in water or diluted fruit juice. It's important not to accept the medication if the printed seal under the cap is missing or broken. It should be stored in a tight, light-resistant container as defined in the USP, at 20° to 25°C (68°to 77°F), with excursions permitted to 15° 10 30°C (69°to 86°F)[see USP Gontralled Room Temperature]. A medication guide should be dispensed to each patient.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 5 mg Blister Carton (10 x 10 Unit-dose) - lamotrigine fig5

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 5 mg Blister Carton (10 x 10 Unit-dose) - lamotrigine fig5

The text is promoting Lamotrigine Tablets for Oral Suspension, USP. Each tablet contains 5mg of Lamotrigine USP and can be taken as a whole or dispersed in water or diluted fruit juice. The dosage information is found in the prescribing information. It comes in a tightly sealed, light-resistant container and should be stored between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F.) The medication guide should be dispensed to each patient. Distributed by Aurobindo Pharma USA, Inc. Made in India.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 25 mg (100 Tablets Bottle) - lamotrigine fig6

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 25 mg (100 Tablets Bottle) - lamotrigine fig6

This is a medication guide for Lamotrigine Tablets for Oral Suspension. Each tablet contains Lamotrigine USP 25 mg. The tablets can be swallowed whole, chewed, or dispersed in water or diluted juice. The medication guide should be distributed to each patient. This prescription medicine should only be used according to the prescribing information. The medicine comes in a tight, light-resistant container and should be stored at 20° to 25°C.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 25 mg Blister Carton (10 x 10 Unit-dose) - lamotrigine fig7

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 25 mg Blister Carton (10 x 10 Unit-dose) - lamotrigine fig7

Chemical Structure - lamotrigine str

Chemical Structure - lamotrigine str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.